<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/62C544E8-A6D5-4B0C-9773-7A30B21F968D"><gtr:id>62C544E8-A6D5-4B0C-9773-7A30B21F968D</gtr:id><gtr:name>University of Padua</gtr:name><gtr:address><gtr:line1>Universita di Padova</gtr:line1><gtr:line4>Padova</gtr:line4><gtr:postCode>35129</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FE1EC3EB-3D38-4ABB-94B2-8429AC475C8F"><gtr:id>FE1EC3EB-3D38-4ABB-94B2-8429AC475C8F</gtr:id><gtr:name>Northwestern University</gtr:name><gtr:address><gtr:line1>633 Clark Street</gtr:line1><gtr:postCode>60208</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0AEFDD04-383A-4977-9F05-440376448760"><gtr:id>0AEFDD04-383A-4977-9F05-440376448760</gtr:id><gtr:name>International Centre for Genetic Engineering and Biotechnology</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D6C3234E-5048-4AA0-A116-0CAC51569B2D"><gtr:id>D6C3234E-5048-4AA0-A116-0CAC51569B2D</gtr:id><gtr:name>University of Queensland</gtr:name><gtr:address><gtr:line1>University of Queensland</gtr:line1><gtr:line4>Brisbane</gtr:line4><gtr:line5>Queensland 4972</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:department>Medical Research Council</gtr:department><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/62C544E8-A6D5-4B0C-9773-7A30B21F968D"><gtr:id>62C544E8-A6D5-4B0C-9773-7A30B21F968D</gtr:id><gtr:name>University of Padua</gtr:name><gtr:address><gtr:line1>Universita di Padova</gtr:line1><gtr:line4>Padova</gtr:line4><gtr:postCode>35129</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FE1EC3EB-3D38-4ABB-94B2-8429AC475C8F"><gtr:id>FE1EC3EB-3D38-4ABB-94B2-8429AC475C8F</gtr:id><gtr:name>Northwestern University</gtr:name><gtr:address><gtr:line1>633 Clark Street</gtr:line1><gtr:postCode>60208</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0AEFDD04-383A-4977-9F05-440376448760"><gtr:id>0AEFDD04-383A-4977-9F05-440376448760</gtr:id><gtr:name>International Centre for Genetic Engineering and Biotechnology</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D6C3234E-5048-4AA0-A116-0CAC51569B2D"><gtr:id>D6C3234E-5048-4AA0-A116-0CAC51569B2D</gtr:id><gtr:name>University of Queensland</gtr:name><gtr:address><gtr:line1>University of Queensland</gtr:line1><gtr:line4>Brisbane</gtr:line4><gtr:line5>Queensland 4972</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/0FEA323B-5383-4C1C-A72E-0D58CEA05208"><gtr:id>0FEA323B-5383-4C1C-A72E-0D58CEA05208</gtr:id><gtr:firstName>Majid</gtr:firstName><gtr:surname>Hafezparast</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E9569DBF-D927-490E-8091-94808DE45807"><gtr:id>E9569DBF-D927-490E-8091-94808DE45807</gtr:id><gtr:firstName>Joanne</gtr:firstName><gtr:surname>Martin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/201636C4-A28A-45C9-B123-C1341019BBA0"><gtr:id>201636C4-A28A-45C9-B123-C1341019BBA0</gtr:id><gtr:firstName>Elizabeth</gtr:firstName><gtr:surname>Fisher</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A3DB76B2-176A-4ED2-A07B-E587E9D577C6"><gtr:id>A3DB76B2-176A-4ED2-A07B-E587E9D577C6</gtr:id><gtr:firstName>Linda</gtr:firstName><gtr:surname>Greensmith</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500288"><gtr:id>3D503D00-33CF-49FA-91C9-7452BA792F5E</gtr:id><gtr:title>Dissecting the processes of motor neuron disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500288</gtr:grantReference><gtr:abstractText>All four applicants consider the public dissemination of science at all levels, to be paramount, especially for subjects such as genetics and neurobiology. They have all lectured to non-specialists ranging from CEOs of leading utility companies to local school children, and at the Royal Institution to the Science Museum. In addition, for example, EF was a BA Media Fellow and worked for 8 weeks in the BBC World Service, conveying science to an international audience, and still has strong ties to the Association of British Science Writers including judging their 2003 and 2004 ABSW awards. All groups also regularly give talks to the lay public in Patients and Carers groups.</gtr:abstractText><gtr:technicalSummary>This Research Grant application is for a 4-year focussed mutagenesis project to create a resource for functionally dissecting the mechanism of mutant SOD1 action and neurodegeneration. 
 
Motor neuron diseases (MNDs) are relatively common (1 in 500 death certificates is issued for some form of MND) and can strike at any age ? spinal muscular atrophy is the biggest single genetic killer of children world-wide, whereas amyotrophic lateral sclerosis is a disease of mid-life (40s, 50s). These disease progress inexorably to paralysis and death and we have no treatments that significantly improve quality of life or lifespan of sufferers. Clearly MNDs have a genetic component and are genetically heterogeneous, however only one major effect causative gene, SOD1 has been found (in 1993) and we still have no idea as to its toxic gain of function. Thus there are 2 key issues in MND research, which are also relevant to basic neurobiology studies of motor neuron function:
1. what is the toxic gain of function of mutant SOD1?
2. what other genes and hence pathways are associated with MN death and dysfunction?

We will attack these questions in an innovative Program that capitalises on the unique combination of the genetics and phenotyping skills of our groups, our existing collaborations with a wide range of scientists and clinicians, and access to one of the world?s premier mouse resources at MRC Harwell. We will set up a SENSITISED-SCREEN to look for genes/pathways that specifically affect the toxic gain of function of mutant SOD1. We will use the resulting set of new mutations as a future resource for us and the MND community for detailed phenotypic and genetic analysis to dissect molecular processes leading us to important cell biological pathways involved in the mutant SOD1 gain of function, ultimately for translation into therapeutic targets.</gtr:technicalSummary><gtr:fund><gtr:end>2009-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>653035</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Queensland</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Looking at gliosis in neurodegeneration</gtr:description><gtr:id>5C441803-3193-4582-A514-C6A228CD8AD2</gtr:id><gtr:impact>No outputs yet</gtr:impact><gtr:outcomeId>5898b9722e07a9.37396566-1</gtr:outcomeId><gtr:partnerContribution>Analysis of gliosis and potentially the inflammasome</gtr:partnerContribution><gtr:piContribution>Access to unique mouse models and crosses</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Padova</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Department of Neurosciences</gtr:department><gtr:description>studying ribosomal proteins</gtr:description><gtr:id>346C2567-8E20-4C9B-9AED-E2604CA2D8BF</gtr:id><gtr:impact>No outputs yet</gtr:impact><gtr:outcomeId>5898ba13461a67.34112971-1</gtr:outcomeId><gtr:partnerContribution>Analysis of ribosomal proteins</gtr:partnerContribution><gtr:piContribution>Access to a unique mouse model of FUS ALS (Delta14)</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sussex</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Life Sciences Sussex</gtr:department><gtr:description>molecular cell biology of neurons</gtr:description><gtr:id>558326FD-D0F5-4BB3-B9D9-9688BB66FC5C</gtr:id><gtr:impact>publications</gtr:impact><gtr:outcomeId>FAeAhLmsFGL-1</gtr:outcomeId><gtr:partnerContribution>expertisei n molecular neurobiology</gtr:partnerContribution><gtr:piContribution>supplying mouse resources and cells</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Earth Sciences</gtr:department><gtr:description>Analysing the metabolome Griffin, Cambridge</gtr:description><gtr:id>BDBEFB6E-774A-4470-8488-B6F2609F678A</gtr:id><gtr:impact>No outputs yet</gtr:impact><gtr:outcomeId>5898b8f7e3ff69.75356625-1</gtr:outcomeId><gtr:partnerContribution>Analysis of the metabolome including lipidomics</gtr:partnerContribution><gtr:piContribution>Access to novel mice and mouse crosses</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Advanced Bioimaging</gtr:department><gtr:description>Imaging</gtr:description><gtr:id>EF7706FA-0D29-4653-A65F-8389B89E4C3E</gtr:id><gtr:impact>Papers, studentships.</gtr:impact><gtr:outcomeId>CkUTwpkD8eL-1</gtr:outcomeId><gtr:partnerContribution>High resolution imaging</gtr:partnerContribution><gtr:piContribution>Mouse models</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Centre for Genetic Engineering and Biotechnology</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Physiology of new mouse models of motor neuron disease</gtr:description><gtr:id>E3EEA391-2712-4DCA-85D9-FCE309AF8592</gtr:id><gtr:impact>Assessing mouse models for relevance to human disease. Publications pending. This has been and remains an extremely important collaboration for my research.</gtr:impact><gtr:outcomeId>DC5FC3F1A32-3</gtr:outcomeId><gtr:partnerContribution>Physiological analysis of new mouse models of a human disease, and cellular and molecular analysis of these models.</gtr:partnerContribution><gtr:piContribution>Contributing new mouse models and personnel.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Northwestern University Chicago</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Ken &amp; Ruth Davee Department of Neurology</gtr:department><gtr:description>Physiology of new mouse models of motor neuron disease</gtr:description><gtr:id>8821131C-1161-4052-BBCC-C6AB4E10BD83</gtr:id><gtr:impact>Assessing mouse models for relevance to human disease. Publications pending. This has been and remains an extremely important collaboration for my research.</gtr:impact><gtr:outcomeId>DC5FC3F1A32-2</gtr:outcomeId><gtr:partnerContribution>Physiological analysis of new mouse models of a human disease, and cellular and molecular analysis of these models.</gtr:partnerContribution><gtr:piContribution>Contributing new mouse models and personnel.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Physiology of new mouse models of motor neuron disease</gtr:description><gtr:id>C2131CE1-5B3C-4E76-BA2B-53F5576FA602</gtr:id><gtr:impact>Assessing mouse models for relevance to human disease. Publications pending. This has been and remains an extremely important collaboration for my research.</gtr:impact><gtr:outcomeId>DC5FC3F1A32-1</gtr:outcomeId><gtr:partnerContribution>Physiological analysis of new mouse models of a human disease, and cellular and molecular analysis of these models.</gtr:partnerContribution><gtr:piContribution>Contributing new mouse models and personnel.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Marie Curie Palliative Care Research Department</gtr:department><gtr:description>Analysis of the FUS mouse translatome, Fratta, UCL</gtr:description><gtr:id>70595CF7-B436-4F53-94B3-04E86CC700B8</gtr:id><gtr:impact>Multidisiplinary output. No outcomes yet as just started.</gtr:impact><gtr:outcomeId>5898b86b1ada10.87827480-1</gtr:outcomeId><gtr:partnerContribution>RiboTagging and ChatCre breeding to pull down polysomes from the Delta14 mouse</gtr:partnerContribution><gtr:piContribution>contribution of the unique FUS Delta14 mouse model</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>lay meeting motor neuron disease association</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F683CF4C-ED1F-4206-B6A7-93339B4CB6AA</gtr:id><gtr:impact>Talking with potential funders affected by motor neuron disease, with the Motor Neuron Disease Association.

Believe helped towards contribution made to the Motor Neuron Disease Association.</gtr:impact><gtr:outcomeId>327E9BFBD30</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Private meeting with major funders</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>375C05B9-D00A-41D7-B762-DC5E9B4A2E8C</gtr:id><gtr:impact>Private meeting to inform major funders of research in motor neuron disease supported by the charity in question.

Maintaining funders enthusiasm and interest and showing value for money.</gtr:impact><gtr:outcomeId>mXpaLs3bSFk</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>Pre-2006,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Open day for patients</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0B0FD3B4-3466-4395-A1ED-1171D9363A97</gtr:id><gtr:impact>Talking directly to patients and carers about animal research and how we work with animals to understand motor neuron disease.

Telling patients about the current state of our work.</gtr:impact><gtr:outcomeId>K7wVf9agZa4</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>88690</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship MNDA Humanizing the Tardbp (TDP43) locus in the mouse</gtr:description><gtr:end>2018-11-02</gtr:end><gtr:fundingOrg>Motor Neurone Disease Association (MND)</gtr:fundingOrg><gtr:fundingRef>Fisher (10/442)</gtr:fundingRef><gtr:id>F26DC08D-F192-4799-B9E7-D73C66B7BB19</gtr:id><gtr:outcomeId>589cac1b5dfcd9.27848008</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>82606</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MNDA PhD Studentship</gtr:description><gtr:end>2011-10-02</gtr:end><gtr:fundingOrg>Motor Neurone Disease Association (MND)</gtr:fundingOrg><gtr:id>C38F46D5-E740-4527-A973-BCAE2FE33CE5</gtr:id><gtr:outcomeId>FFFF81997760</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research grant</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Thierry Latran Foundation</gtr:fundingOrg><gtr:id>BFBB1EEF-5588-4CB1-89B7-EA88CE961BC8</gtr:id><gtr:outcomeId>DCFECA99EEA0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>110000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MNDA PhD Studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Motor Neurone Disease Association (MND)</gtr:fundingOrg><gtr:id>C6D6A368-3569-4A27-A2A2-D856BCCE443D</gtr:id><gtr:outcomeId>noZMJdkcHnU</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NC3Rs PhD studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:id>03F66B94-9986-4907-8825-449B167E7A1C</gtr:id><gtr:outcomeId>CMXJz55vW65</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>254819</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MNDA Research Grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Motor Neurone Disease Association (MND)</gtr:fundingOrg><gtr:id>18A1A299-78F3-4F9E-9C5A-E3E700031FE2</gtr:id><gtr:outcomeId>B53EADA74A90</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MNDA Small Grant</gtr:description><gtr:end>2008-12-02</gtr:end><gtr:fundingOrg>Motor Neurone Disease Association (MND)</gtr:fundingOrg><gtr:id>92ACDDFD-3930-4FE4-9751-3961B759BEEC</gtr:id><gtr:outcomeId>62F4AF840B70</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Humanised genomic wildtype FUS gene in mouse</gtr:description><gtr:id>EBCE7EFF-3B4F-422B-A68C-5FE0F4093251</gtr:id><gtr:impact>Pending</gtr:impact><gtr:outcomeId>56c753f4b749c4.82037557</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Mouse humanised wildtype FUS model</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Mouse models of motor neuron degeneration, with a specific mutation in the gene FUS (delta 14)</gtr:description><gtr:id>C821F9DB-6E7E-4E13-A4A0-14F23719C971</gtr:id><gtr:impact>Papers pending, and model is basis of two new grant applications (both successful)</gtr:impact><gtr:outcomeId>1D337ED548C</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>mouse models for fus mnd delta 14 only</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E2BEE155-D164-45DA-837C-C75880C9B588</gtr:id><gtr:title>A point mutation in TRPC3 causes abnormal Purkinje cell development and cerebellar ataxia in moonwalker mice.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f34af4d2e8574f0b217df6dd39dd652"><gtr:id>3f34af4d2e8574f0b217df6dd39dd652</gtr:id><gtr:otherNames>Becker EB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>D8071B661D1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48B270E2-DE9C-4FF5-8E4D-9CA23285FEE5</gtr:id><gtr:title>TDP-43 is a culprit in human neurodegeneration, and not just an innocent bystander.</gtr:title><gtr:parentPublicationTitle>Mammalian genome : official journal of the International Mammalian Genome Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b340eec681d243ded9a96296147e0c6"><gtr:id>5b340eec681d243ded9a96296147e0c6</gtr:id><gtr:otherNames>Banks GT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0938-8990</gtr:issn><gtr:outcomeId>B2075A84666</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF5A21AE-F1A5-473F-BA47-9A7020EBF267</gtr:id><gtr:title>Sequencing analysis of the spinal bulbar muscular atrophy CAG expansion reveals absence of repeat interruptions.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d1a7eafc9d349e2e6367fcc16d31c49"><gtr:id>8d1a7eafc9d349e2e6367fcc16d31c49</gtr:id><gtr:otherNames>Fratta P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>P6eTCQk7aYJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B4C12F2-F689-4E0E-9205-5631307B2846</gtr:id><gtr:title>A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d0c58f3e65f2f0c33dd5d66cc31fb81"><gtr:id>7d0c58f3e65f2f0c33dd5d66cc31fb81</gtr:id><gtr:otherNames>Acevedo-Arozena A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>56c74134a17525.55462563</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B348531-391A-412B-A698-4796020A4301</gtr:id><gtr:title>ENU mutagenesis reveals a novel phenotype of reduced limb strength in mice lacking fibrillin 2.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/529658a9cdd14ca4e07f174b9c438cce"><gtr:id>529658a9cdd14ca4e07f174b9c438cce</gtr:id><gtr:otherNames>Miller G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13775_25_20161761</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DDC196F-0FB6-43D8-AB5A-DBA35BB1ECDF</gtr:id><gtr:title>Sequencing analysis of the ITPR1 gene in a pure autosomal dominant spinocerebellar ataxia series.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/673eb3a354040dbcb56dbe98ec677ebe"><gtr:id>673eb3a354040dbcb56dbe98ec677ebe</gtr:id><gtr:otherNames>van de Leemput J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_13775_25_20437544</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>475DAE75-73AD-48A2-8F0E-CB413E9492CB</gtr:id><gtr:title>Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d1a7eafc9d349e2e6367fcc16d31c49"><gtr:id>8d1a7eafc9d349e2e6367fcc16d31c49</gtr:id><gtr:otherNames>Fratta P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>544fc67ade5399.31223299</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F83AFC93-1804-4062-BED3-AA09EBB4F288</gtr:id><gtr:title>Deficiency of the zinc finger protein ZFP106 causes motor and sensory neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccd7dfc8b2f380f88687cbf25b84d0f2"><gtr:id>ccd7dfc8b2f380f88687cbf25b84d0f2</gtr:id><gtr:otherNames>Joyce PI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5656e2a583d376.78334910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F635013C-B536-4D2A-BE9B-059EDBF85004</gtr:id><gtr:title>Neurodegenerative mutation in cytoplasmic dynein alters its organization and dynein-dynactin and dynein-kinesin interactions.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf1da2f3bea9c7ce4cb493f5c7e25f3b"><gtr:id>cf1da2f3bea9c7ce4cb493f5c7e25f3b</gtr:id><gtr:otherNames>Deng W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_13775_25_20889981</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29D8E5F9-98B0-45B4-A4AF-0CBD6CFC59E7</gtr:id><gtr:title>The phagocytic capacity of neurones.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8d7d60799d289b516a317c4737223f0"><gtr:id>b8d7d60799d289b516a317c4737223f0</gtr:id><gtr:otherNames>Bowen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>nizagJwssHz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51CBB5D9-E9A7-46D8-883B-458762D42BF1</gtr:id><gtr:title>DYNC1H1 mutation alters transport kinetics and ERK1/2-cFos signalling in a mouse model of distal spinal muscular atrophy.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab7e05a684ce65aeb5dfb46f23c53e4b"><gtr:id>ab7e05a684ce65aeb5dfb46f23c53e4b</gtr:id><gtr:otherNames>Garrett CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>544fc789122568.02468256</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2D7B6AE-3A4E-4078-86C9-AD35A6E86697</gtr:id><gtr:title>Cytoplasmic dynein could be key to understanding neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b340eec681d243ded9a96296147e0c6"><gtr:id>5b340eec681d243ded9a96296147e0c6</gtr:id><gtr:otherNames>Banks GT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>01741BEBA73</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E9D9B1F-C809-4E55-9DB6-318640D109DC</gtr:id><gtr:title>Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/673eb3a354040dbcb56dbe98ec677ebe"><gtr:id>673eb3a354040dbcb56dbe98ec677ebe</gtr:id><gtr:otherNames>van de Leemput J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>odvCEefNQNQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62546C2D-8475-41C1-921C-1252AEF84AE1</gtr:id><gtr:title>Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9ddd65d8294adde2619328d3384b1cd"><gtr:id>f9ddd65d8294adde2619328d3384b1cd</gtr:id><gtr:otherNames>Chia R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13775_25_20498711</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7BCC2E4-5F1F-4F08-AC00-DC7EB6EB2E09</gtr:id><gtr:title>Is SOD1 loss of function involved in amyotrophic lateral sclerosis?</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03fd54e97f8d443160f933229c72f332"><gtr:id>03fd54e97f8d443160f933229c72f332</gtr:id><gtr:otherNames>Saccon RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>544fc4972f70f7.41638382</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23B0D0D4-20D2-4E8E-8BBD-1F177911176C</gtr:id><gtr:title>A novel phenotype for the dynein heavy chain mutation Loa: altered dendritic morphology, organelle density, and reduced numbers of trigeminal motoneurons.</gtr:title><gtr:parentPublicationTitle>The Journal of comparative neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bf7e8b693badb2145d398698bc941c2"><gtr:id>0bf7e8b693badb2145d398698bc941c2</gtr:id><gtr:otherNames>Wiggins LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9967</gtr:issn><gtr:outcomeId>56c7412e3ffb69.20060487</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D8F9812-64B4-4578-ABC3-3470C3191929</gtr:id><gtr:title>A nonsense mutation in mouse Tardbp affects TDP43 alternative splicing activity and causes limb-clasping and body tone defects.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/311b04aa4c17b316103c9775174f68e9"><gtr:id>311b04aa4c17b316103c9775174f68e9</gtr:id><gtr:otherNames>Ricketts T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56c7413186a4f3.37238760</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70B3B680-C3EF-4F3E-BCA5-B34674A5177F</gtr:id><gtr:title>An unusual presentation for SOD1-ALS: isolated facial diplegia.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d1a7eafc9d349e2e6367fcc16d31c49"><gtr:id>8d1a7eafc9d349e2e6367fcc16d31c49</gtr:id><gtr:otherNames>Fratta P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>SKy2pXyuAV4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31953007-069B-4CEB-9C7F-1167AEA69F45</gtr:id><gtr:title>Behavioral and other phenotypes in a cytoplasmic Dynein light intermediate chain 1 mutant mouse.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b340eec681d243ded9a96296147e0c6"><gtr:id>5b340eec681d243ded9a96296147e0c6</gtr:id><gtr:otherNames>Banks GT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>56c74134f06f69.37951743</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1154E850-09F9-401D-8997-9056B4C8C944</gtr:id><gtr:title>The legs at odd angles (Loa) mutation in cytoplasmic dynein ameliorates mitochondrial function in SOD1G93A mouse model for motor neuron disease.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67850162a1b7fefe9245641a6e9ad020"><gtr:id>67850162a1b7fefe9245641a6e9ad020</gtr:id><gtr:otherNames>El-Kadi AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_13775_25_20382740</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F132337-1417-4325-9C59-C7697FF1C95C</gtr:id><gtr:title>SOD1 Function and Its Implications for Amyotrophic Lateral Sclerosis Pathology: New and Renascent Themes.</gtr:title><gtr:parentPublicationTitle>The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b43d32f2b6cfef312c3c6a528071c8e6"><gtr:id>b43d32f2b6cfef312c3c6a528071c8e6</gtr:id><gtr:otherNames>Bunton-Stasyshyn RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1073-8584</gtr:issn><gtr:outcomeId>5656e2ec9d6691.06050898</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>227637E6-AB2F-4079-857F-ED7BA73BF1B9</gtr:id><gtr:title>Modification of superoxide dismutase 1 (SOD1) properties by a GFP tag--implications for research into amyotrophic lateral sclerosis (ALS).</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abc3f233f373ed02719f6b6d5e5fa937"><gtr:id>abc3f233f373ed02719f6b6d5e5fa937</gtr:id><gtr:otherNames>Stevens JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13775_25_20221404</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D169C83E-9240-4813-9199-8F1B42FBB4C6</gtr:id><gtr:title>C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d1a7eafc9d349e2e6367fcc16d31c49"><gtr:id>8d1a7eafc9d349e2e6367fcc16d31c49</gtr:id><gtr:otherNames>Fratta P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>HProjLWHPta</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C28424E9-8676-4D29-AFDE-20C43F522946</gtr:id><gtr:title>Rodent models of amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52d08fa06edfabbc102dfeef4a0e4f35"><gtr:id>52d08fa06edfabbc102dfeef4a0e4f35</gtr:id><gtr:otherNames>McGoldrick P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>544fc503ad93c8.06100467</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CCE4793-B3EB-4C8C-B990-890FCE7DD543</gtr:id><gtr:title>A motor-driven mechanism for cell-length sensing.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a068ee28f50767617003e549e2b63703"><gtr:id>a068ee28f50767617003e549e2b63703</gtr:id><gtr:otherNames>Rishal I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>56c7412e6f8951.63648923</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80872517-4496-498C-940A-669F02D5C9FC</gtr:id><gtr:title>Cytoplasmic dynein heavy chain: the servant of many masters.</gtr:title><gtr:parentPublicationTitle>Trends in neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c944bcf656a481a3b947faf567b80d7"><gtr:id>5c944bcf656a481a3b947faf567b80d7</gtr:id><gtr:otherNames>Schiavo G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0166-2236</gtr:issn><gtr:outcomeId>544fc577ae7988.78105288</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3BB9095-4855-4CA0-AC3C-D641F85BFB30</gtr:id><gtr:title>How does the genetic assassin select its neuronal target?</gtr:title><gtr:parentPublicationTitle>Mammalian genome : official journal of the International Mammalian Genome Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abc3f233f373ed02719f6b6d5e5fa937"><gtr:id>abc3f233f373ed02719f6b6d5e5fa937</gtr:id><gtr:otherNames>Stevens JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0938-8990</gtr:issn><gtr:outcomeId>pm_13775_25_21373885</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A882847-5B83-4D16-BB16-85428C18ED6C</gtr:id><gtr:title>Quiet mutations in inbred strains of mice.</gtr:title><gtr:parentPublicationTitle>Trends in molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abc3f233f373ed02719f6b6d5e5fa937"><gtr:id>abc3f233f373ed02719f6b6d5e5fa937</gtr:id><gtr:otherNames>Stevens JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1471-4914</gtr:issn><gtr:outcomeId>917658A064C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>751DEC2E-FD4C-4A1B-AD84-ED98FE18DF81</gtr:id><gtr:title>A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccd7dfc8b2f380f88687cbf25b84d0f2"><gtr:id>ccd7dfc8b2f380f88687cbf25b84d0f2</gtr:id><gtr:otherNames>Joyce PI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>56c74132e73704.90753659</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A953AAA5-9350-450A-B6F7-7EABC1C8FA23</gtr:id><gtr:title>Graphical modelling of molecular networks underlying sporadic inclusion body myositis.</gtr:title><gtr:parentPublicationTitle>Molecular bioSystems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d5d2ace43ac20075ac8ea1ef8005d62"><gtr:id>7d5d2ace43ac20075ac8ea1ef8005d62</gtr:id><gtr:otherNames>Thorne T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-2051</gtr:issn><gtr:outcomeId>Zcdkop6XvTi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26C4E97A-C838-4908-8350-16866AB75178</gtr:id><gtr:title>Dynein-dynactin complex subunits are differentially localized in brain and spinal cord, with selective involvement in pathological features of neurodegenerative disease.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4a54e7510f59f2cd19e061051e11c63"><gtr:id>a4a54e7510f59f2cd19e061051e11c63</gtr:id><gtr:otherNames>Ateh DD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>NZHwQMFDjzf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A7B1150-D7DD-4287-AE19-5A1EFFCDBA9D</gtr:id><gtr:title>An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e78549a28b33ad69cc45ce2d814a8585"><gtr:id>e78549a28b33ad69cc45ce2d814a8585</gtr:id><gtr:otherNames>Achilli F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>E7D2992FBF4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B78D4D19-ECE1-460F-8900-4C55585E0470</gtr:id><gtr:title>FUS is not dysregulated by the spinal bulbar muscular atrophy androgen receptor polyglutamine repeat expansion.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d1a7eafc9d349e2e6367fcc16d31c49"><gtr:id>8d1a7eafc9d349e2e6367fcc16d31c49</gtr:id><gtr:otherNames>Fratta P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56c7412f3cd118.86198732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4A0A2E7-61FF-47F3-988F-798FC580EFED</gtr:id><gtr:title>Mutant glycyl-tRNA synthetase (Gars) ameliorates SOD1(G93A) motor neuron degeneration phenotype but has little affect on Loa dynein heavy chain mutant mice.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b340eec681d243ded9a96296147e0c6"><gtr:id>5b340eec681d243ded9a96296147e0c6</gtr:id><gtr:otherNames>Banks GT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>025B12B3DAD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B177C9D-6E72-4596-B176-160CA48C23C7</gtr:id><gtr:title>SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments.</gtr:title><gtr:parentPublicationTitle>Mammalian genome : official journal of the International Mammalian Genome Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccd7dfc8b2f380f88687cbf25b84d0f2"><gtr:id>ccd7dfc8b2f380f88687cbf25b84d0f2</gtr:id><gtr:otherNames>Joyce PI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0938-8990</gtr:issn><gtr:outcomeId>56c7413567c975.48707009</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500288</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>